These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21310223)

  • 41. Relative response factor determination of β-artemether degradants by a dry heat stress approach.
    De Spiegeleer BM; D'Hondt M; Vangheluwe E; Vandercruyssen K; De Spiegeleer BV; Jansen H; Koijen I; Van Gompel J
    J Pharm Biomed Anal; 2012 Nov; 70():111-6. PubMed ID: 22770733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The absolute configuration of (+)- and (-)-erythro-mefloquine.
    Müller M; Orben CM; Schützenmeister N; Schmidt M; Leonov A; Reinscheid UM; Dittrich B; Griesinger C
    Angew Chem Int Ed Engl; 2013 Jun; 52(23):6047-9. PubMed ID: 23616269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, macrophage uptake, and toxicity.
    Kronberg B; Dahlman A; Carlfors J; Karlsson J; Artursson P
    J Pharm Sci; 1990 Aug; 79(8):667-71. PubMed ID: 2231327
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trapped in misbelief for almost 40 years: selective synthesis of the four stereoisomers of mefloquine.
    Schützenmeister N; Müller M; Reinscheid UM; Griesinger C; Leonov A
    Chemistry; 2013 Dec; 19(51):17584-8. PubMed ID: 24226934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of liposome suspensions by flow cytometry.
    Childers NK; Michalek SM; Eldridge JH; Denys FR; Berry AK; McGhee JR
    J Immunol Methods; 1989 Apr; 119(1):135-43. PubMed ID: 2708825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attrition-Enhanced Deracemization of the Antimalaria Drug Mefloquine.
    Engwerda AHJ; Maassen R; Tinnemans P; Meekes H; Rutjes FPJT; Vlieg E
    Angew Chem Int Ed Engl; 2019 Feb; 58(6):1670-1673. PubMed ID: 30508314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Robust, Recyclable Resin for Decagram Scale Resolution of (±)-Mefloquine and Other Chiral N-Heterocycles.
    Kreituss I; Chen KY; Eitel SH; Adam JM; Wuitschik G; Fettes A; Bode JW
    Angew Chem Int Ed Engl; 2016 Jan; 55(4):1553-6. PubMed ID: 26663345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A rapid spectrophotometric method for the determination of mefloquine hydrochloride.
    Rao AB; Murthy RS
    J Pharm Biomed Anal; 2002 Mar; 27(6):959-65. PubMed ID: 11836059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polyphenolic Extract from
    Păvăloiu RD; Sha'at F; Bubueanu C; Deaconu M; Neagu G; Sha'at M; Anastasescu M; Mihailescu M; Matei C; Nechifor G; Berger D
    Nanomaterials (Basel); 2019 Dec; 10(1):. PubMed ID: 31881758
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognosticating the effect of temperature and pH parameters on size and stability of the nanoliposome system based on thermodynamic modeling.
    Rahimi F; Hajizadeh P; Amoabediny G; Ebrahimi B; Khaledi M; Sameni F; Afkhami H; Bakhti S; Rafiee Taqanaki E; Zafari M
    J Liposome Res; 2023 Dec; 33(4):392-409. PubMed ID: 37171257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel Inhalable Dry Powder to Trigger Delivery of Voriconazole for Effective Management of Pulmonary Aspergillosis.
    Almurshedi AS; Almarshad SN; Bukhari SI; Aldosari BN; Alhabardi SA; Alkathiri FA; Saleem I; Aldosar NS; Zaki RM
    Pharmaceutics; 2024 Jul; 16(7):. PubMed ID: 39065594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A toxicity profile of the Pheroid® technology in rodents.
    Kleynhans J; Elgar D; Ebenhan T; Zeevaart JR; Kotzé A; Grobler A
    Toxicol Rep; 2019; 6():940-950. PubMed ID: 31673495
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of liposomes formulation and preparation method on the stability of acyclovir palmitate liposomes].
    Liu H; Tang R; He XX; Zhang Y
    Yao Xue Xue Bao; 2002 Jul; 37(7):563-6. PubMed ID: 12914330
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formulation and evaluation of Pheroid vesicles containing mefloquine for the treatment of malaria.
    du Plessis LH; Helena C; van Huysteen E; Wiesner L; Kotzé AF
    J Pharm Pharmacol; 2014 Jan; 66(1):14-22. PubMed ID: 24117456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the physical properties and stability of two lipid drug delivery systems containing mefloquine.
    Slabbert C; Plessis LH; Kotzé AF
    Int J Pharm; 2011 May; 409(1-2):209-15. PubMed ID: 21310223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stability of luciferase plasmid entrapped in cationic bilayer vesicles.
    Manosroi A; Thathang K; Werner RG; Schubert R; Manosroi J
    Int J Pharm; 2008 May; 356(1-2):291-9. PubMed ID: 18281170
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.